EP0442769 - Compounds destined for encapsulation in erythrocytes, new derivatives of naloxone and naltrexone [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 07.12.1994 Database last updated on 21.05.2024 | Most recent event Tooltip | 07.12.1994 | Application deemed to be withdrawn | published on 25.01.1995 [1995/04] | Applicant(s) | For all designated states FONDATION NATIONALE DE TRANSFUSION SANGUINE 6, rue Alexandre Cabanel 75739 Paris Cédex 15 / FR | [N/P] |
Former [1991/34] | For all designated states FONDATION NATIONALE DE TRANSFUSION SANGUINE 6, rue Alexandre Cabanel F-75739 Paris Cédex 15 / FR | Inventor(s) | 01 /
Guillaumet, Gérald 2 rue A. Renoir F-45100 Orléans / FR | 02 /
Ropars, Claude 16 rue de la Pinterie F-37550 St Avertin / FR | 03 /
Meunier, Jean-Claude 8 Chemin du Pin, Rebigue F-31320 Castanet Tolosan / FR | [1991/34] | Representative(s) | Warcoin, Jacques, et al Cabinet Regimbeau 20, rue de Chazelles 75847 Paris Cedex 17 / FR | [N/P] |
Former [1991/34] | Warcoin, Jacques, et al Cabinet Régimbeau, 26, avenue Kléber F-75116 Paris / FR | Application number, filing date | 91400127.6 | 21.01.1991 | [1991/34] | Priority number, date | FR19900000613 | 19.01.1990 Original published format: FR 9000613 | [1991/34] | Filing language | FR | Procedural language | FR | Publication | Type: | A2 Application without search report | No.: | EP0442769 | Date: | 21.08.1991 | Language: | FR | [1991/34] | Type: | A3 Search report | No.: | EP0442769 | Date: | 12.02.1992 | Language: | FR | [1992/07] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 19.12.1991 | Classification | IPC: | C07D489/08, C07F9/6561, A61K31/485 | [1991/34] | CPC: |
C07D489/08 (EP);
A61K9/5068 (EP);
C07F9/6561 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, NL, SE [1991/34] | Title | German: | Verbindungen bestimmt zur Verkapselung in Erythrocyten, neue Naloxone- und Naltrexone-Derivate | [1991/34] | English: | Compounds destined for encapsulation in erythrocytes, new derivatives of naloxone and naltrexone | [1991/34] | French: | Composés destinés à l'encapsulation dans les érythrocytes-nouveaux dérivés de la naloxone et naltrexone | [1991/34] | File destroyed: | 15.01.2000 | Examination procedure | 05.08.1992 | Examination requested [1992/40] | 13.04.1994 | Despatch of a communication from the examining division (Time limit: M04) | 02.08.1994 | Application deemed to be withdrawn, date of legal effect [1995/04] | 30.08.1994 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [1995/04] | Fees paid | Renewal fee | 18.01.1993 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.01.1994 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US4673679 | [XD] - JOURNAL OF MEDICINAL CHEMISTRY. vol. 16, no. 5, 1973, WASHINGTON US pages 553 - 556; CHARLES LINDER ET AL.: 'Narcotic antagonists. 1.Isomeric sulfate and acetate esters of naloxone ( N-allylnoroxymorphone)' | [X] - CHEMICAL ABSTRACTS, vol. 84, 1976, Columbus, Ohio, US; abstract no. 130074X, MISRA A.L. ET AL.: 'Physiological disposition and biotransformation of ( allyl-1',3'-14C) naloxone in the rat and some comparative observations on malorphine.' page 6 ; |